Trial Profile
A Pilot Study of Tumor Vaccination and rhIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors and Altered T Cell Homeostasis
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 26 Nov 2009
Price :
$35
*
At a glance
- Drugs Interleukin-7 (Primary) ; Cancer vaccine; Dendritic cell vaccines
- Indications Ewing's sarcoma; Neuroblastoma; Rhabdomyosarcoma; Sarcoma; Solid tumours
- Focus Adverse reactions
- 26 Nov 2009 New trial record.